Introduction to Multicenter Double Blind

What is/are Multicenter Double Blind?

Multicenter Double Blind - Objectives The aim of multicenter double-blind placebo-controlled randomized CT was to investigate the safety and efficacy of Tenoten in the anxiety treatment of adults with SD, RSS, AjD and other neurotic disorders (oNDs). ^[1] STUDY DESIGN We performed an ancillary study to a multicenter double-blind, placebo-controlled randomized clinical trial of erythropoietin in ELGANs. ^[2] High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial. ^[3] To determine the benefits of vitamin D supplementation in pregnancy would require further evaluation through large, multicenter double-blind randomized controlled clinical trials, with a focus on specific adverse pregnancy outcomes. ^[4] Methods A multicenter double-blind randomized controlled trial was conducted in Taiwan from 2014 to 2017. ^[5] Methods: We performed a substudy of the EGASIS trial, a multicenter double-blind, randomized trial in which acute stroke patients were treated with diazepam or placebo for 3 days. ^[6] Conclusions This in vitro study runs parallel to the SAVER trial, a multicenter double-blind randomized controlled trial of SV vs placebo in 110 patients with high-risk OED. ^[7] METHODS We conducted a multicenter double-blind placebo-controlled randomized trial of oral FA (5 mg/d for 12 wk) in middle-aged patients treated with antidepressant medication participating in the FoLATED (Folate Augmentation of Treatment-Evaluation for Depression) trial. ^[8] STUDY DESIGN Multicenter double-blind randomized sham-controlled trial. ^[9] Quantitative versus standard pupillary light reflex for early prognostication in comatose cardiac arrest patients: an international prospective multicenter double-blinded study. ^[10] Methods: During this multicenter double-blind placebo-controlled randomized clinical study (NCT03455842) 105 MTX-IR patients with active RA (ACR2010) were assigned (1:1:1) to receive 162 mg of BCD-089 s. ^[11] Methods A 12-month, investigator-initiated, multicenter double-blind, randomized placebo-controlled trial was conducted between September 2014 and February 2018 at 27 US, Canadian and UK sites. ^[12] Methods and findings In a multicenter double-blind trial, hospitalized severely malnourished children were randomized to receive standard formula (F75) or isocaloric modified F75 (mF75) without lactose and with reduced carbohydrate. ^[13] Methods: This is a multicenter double-blind randomized placebo-controlled maintenance trial of adjunctive tianeptine 37. ^[14] A multicenter double-blind clinical study was conducted using the traditional V. ^[15] The authors examined the therapeutic effect of dTMS in a multicenter double-blind sham-controlled study. ^[16] MATERIAL AND METHODS The multicenter double-blind placebo-controlled randomized trial enrolled 184 children (aged 29 days-9 months) with the total score 12-27 according to Djurba-Mastukova scale and the level of physical development 25-75 centiles. ^[17] The ACTCM trial, a prospective multicenter double-blind randomized placebo-controlled study, will recruit 312 patients overall from 5 clinical research centers in China. ^[18] Methods ASSET was a multicenter double-blind, randomized placebo-controlled trial. ^[19] Finally, in future research more objective data and multicenter double-blinded controlled studies should be encouraged. ^[20] OBJECTIVES We conducted a pilot multicenter double-blind randomized placebo-controlled crossover pharmacodynamic study to evaluate the blood pressure (BP) and the hormonal effects of firibastat, a first-in-class aminopeptidase A inhibitor prodrug, in patients with hypertension. ^[21] MethodsThe EXAFIP study is a French national multicenter double-blind placebo-controlled randomized trial. ^[22] DESIGN Secondary analysis based on data from a multicenter double-blind randomized clinical trial. ^[23]

placebo controlled randomized

Objectives The aim of multicenter double-blind placebo-controlled randomized CT was to investigate the safety and efficacy of Tenoten in the anxiety treatment of adults with SD, RSS, AjD and other neurotic disorders (oNDs). ^[1] STUDY DESIGN We performed an ancillary study to a multicenter double-blind, placebo-controlled randomized clinical trial of erythropoietin in ELGANs. ^[2] METHODS We conducted a multicenter double-blind placebo-controlled randomized trial of oral FA (5 mg/d for 12 wk) in middle-aged patients treated with antidepressant medication participating in the FoLATED (Folate Augmentation of Treatment-Evaluation for Depression) trial. ^[3] Methods: During this multicenter double-blind placebo-controlled randomized clinical study (NCT03455842) 105 MTX-IR patients with active RA (ACR2010) were assigned (1:1:1) to receive 162 mg of BCD-089 s. ^[4] MATERIAL AND METHODS The multicenter double-blind placebo-controlled randomized trial enrolled 184 children (aged 29 days-9 months) with the total score 12-27 according to Djurba-Mastukova scale and the level of physical development 25-75 centiles. ^[5] MethodsThe EXAFIP study is a French national multicenter double-blind placebo-controlled randomized trial. ^[6]

randomized placebo controlled

Methods A 12-month, investigator-initiated, multicenter double-blind, randomized placebo-controlled trial was conducted between September 2014 and February 2018 at 27 US, Canadian and UK sites. ^[1] Methods: This is a multicenter double-blind randomized placebo-controlled maintenance trial of adjunctive tianeptine 37. ^[2] The ACTCM trial, a prospective multicenter double-blind randomized placebo-controlled study, will recruit 312 patients overall from 5 clinical research centers in China. ^[3] Methods ASSET was a multicenter double-blind, randomized placebo-controlled trial. ^[4] OBJECTIVES We conducted a pilot multicenter double-blind randomized placebo-controlled crossover pharmacodynamic study to evaluate the blood pressure (BP) and the hormonal effects of firibastat, a first-in-class aminopeptidase A inhibitor prodrug, in patients with hypertension. ^[5]